Scientists at Charité -- Universitätsmedizin Berlin have succeeded in coming closer to determining the risk of relapse in detoxified alcohol-dependent patients. Using an imaging process (magnetic resonance tomography) it was shown that particular regions in the brain demonstrate structural as well as functional abnormalities in relapsed alcohol-dependent patients. Study findings are published in the journal Archives of General Psychiatry.

In the study conducted under the direction of Prof. Andreas Heinz, director of the Charité Department of Psychiatry and Psychotherapy, scientists examined a group of 46 detoxified alcohol-dependent patients, in addition to a large control group. Structural imaging showed anatomical properties of brain substance, and the examination of functional signals in the brain were measured in reaction to alcohol-associated stimuli. After three months, patients were reexamined for eventual relapses; 30 study participants relapsed and 16 continued to be abstinent.

It was proven that relapse patients had increased loss of grey matter in particular regions of the forebrain. This section of the brain is known to be associated primarily with behavioral regulation and emotional control. Furthermore, measurement of functional brain responses in reaction to alcohol-associated stimuli showed that different brain regions were activated in relapsed patients than in patients who remained abstinent. These measurements show that sections of the brain in relapse patients were active that are associated primarily with directing attention to certain stimuli. In contrast, the abstinent patients demonstrated an activation of brain areas that are (among other functions) associated with processing of stimuli inducing aversion (aversive stimuli) or that are particularly important (salient stimuli).

In an alarming new study published in the journal Food and Chemical Toxicology, researchers from The Committee for Research & Independent Information on Genetic Engineering (CRIIGEN) reported on the results of a 2 year feeding study in rats given either NK603 Roundup-tolerant genetically modified maize, cultivated with or without Roundup, and Roundup alone, at levels permitted in drinking water and GM crops in the United States.

The authors of the study pointed out that currently, no regulatory authority requires mandatory chronic animal feeding studies to be performed for edible GMOs and formulated pesticides, and the only 90 day feeding trials were conducted by the biotech industry.

This study, therefore, was performed in light of this need, and the results were an unprecedented confirmation of the cancer-causing effects of GM food and agrichemicals, reported as follows:

In females, all treated groups died 2 - 3 times more than controls, and more rapidly. This difference was visible in 3 male groups fed GMOs. All results were hormone and sex dependent, and the pathological profiles were comparable. Females developed large mammary tumors almost always more often than and before controls, the pituitary was the second most disabled organ; the sex hormonal balance was modified by GMO and Roundup treatments. In treated males, liver congestions and necrosis were 2.5 - 5.5 times higher.

This pathology was confirmed by optic and transmission electron microscopy. Marked and severe kidney nephropathies were also generally 1.3 - 2.3 greater. Males presented 4 times more large palpable tumors than controls which occurred up to 600 days earlier. Biochemistry data confirmed very significant kidney chronic deficiencies; for all treatments and both sexes, 76% of the altered parameters were kidney related. These results can be explained by the non linear endocrine-disrupting effects of Roundup, but also by the overexpression of the transgene in the GMO and its metabolic consequences. [emphasis added]

Glycation is one of the most important nutritional discoveries in the last century that deals with health. In this video, Dr. Ellis begins to discuss what glycation is and how people suffer from it daily and may not even know it because everyone is undergoing the glycation process:

Scientists at the Medical College of Wisconsin, in a team led by Carol Everson, Ph.D., professor of neurology, cell biology, neurobiology and anatomy, have discovered abnormalities in bone and bone marrow in rats undergoing chronic lack of sleep. They discovered abnormalities in serum markers of bone metabolism in sleep-deprived rats, which led them to conduct direct measurements of bone parameters; this time in rats experiencing recurrent sleep restriction during a large portion of their young adulthood.

The results show a dramatic imbalance between bone apposition and reabsorption, marked by an arrest in bone formation without reduced absorption. Furthermore, fat in the red marrow is greatly diminished and platelet-generating cells are doubled in number, indicating changes to marrow plasticity. "If the same processes are evoked in humans," said Dr. Everson, "the potential medical implications are far-reaching and may include poor repair of microdamage from activities of daily living, introduction of osteoporotic processes, and changes to progenitor cells that may affect disease predisposition and disease resistance."

Neurosurgeon and researcher Dr. Leif Salford has conducted many studies on radio frequency radiation and its effects on the brain. Dr. Salford called the potential implications of some of his research "terrifying." Some of the most concerning conclusions result from the fact that the weakest exposure levels to wireless radiation caused the greatest effect in causing the blood brain barrier to leak.

Since he began his line of research in 1988, Dr. Leif Salford and his colleagues at Lund University Hospital in Sweden has exposed over 1,600 experimental animals to low-level radiation. Their results were consistent and worrisome: radiation, including that from cell phones, caused the blood-brain barrier--the brain's first line of
defense against infections and toxic chemicals--to leak.

Researchers in 13 other laboratories in 6 different countries had reported the same effect, but no one had proven whether it would lead to any damage in the long term. In a study published June 2003 in Environmental Health Perspectives, Salford's team repeated the experiment on 32 additional animals, but this time waited eight weeks before sacrificing them and examining their brains. In those animals that had been exposed to a cell phone, up to two percent of the neurons in all areas of the brain were shrunken and degenerated.

Salford, chairman of the Department of Neurosurgery at his institution, called the potential implications "terrifying." "We have good reason to believe," he said, "that what happens in rats' brains also happens in humans." Referring to today's teenagers, the study's authors wrote that "a whole generation of users may suffer negative effects, perhaps as early as in middle age."

An estimated 40 million people take a statin to lower their cholesterol levels. These are one of the most widely prescribed medications in history and, of course, one of the most profitable.

We are led to believe that the benefits associated with statins far outweigh any risks. However, when it comes to primary prevention (accounting for around 75 percent of all the people who take a statin), no clinical trial has been able to conclusively show any net benefit.

This is one of the issues discussed in the documentary film STATIN NATION: The Great Cholesterol Cover Up.


If we look at the history of primary prevention clinical trials involving statins, we find that none of the major trials were able to demonstrate a significant reduction in the number of deaths from all causes. The AFCAPS, ASCOT, CARDS, PROSPER and WOSCOPS clinical trials all failed to show a statistically significant reduction in all cause mortality.

This data for deaths from all causes is, of course, important because it is the only measure we can use to determine if the statin is going to extend life expectancy or not.

Whilst some statin clinical trials have shown a very slight reduction in cardiac events, this has always been counter-acted by deaths from other causes. The net result being that people did not live any longer after taking the statin.

Contrary to previous findings, new research finds no link between chronic fatigue syndrome and the viruses XMRV (xenotropic murine leukemia virus-related virus) and pMLV (polytropic murine leukemia virus). A study to be published on September 18 in mBio®, the online open-access journal of the American Society for Microbiology, reveals that research that reported patients with chronic fatigue syndrome carried these two viruses was wrong and that there is still no evidence for an infectious cause behind chronic fatigue syndrome.

"The bottom line is we found no evidence of infection with XMRV and pMLV. These results refute any correlation between these agents and disease," says Ian Lipkin of Columbia University, a co-author on the study.

Chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), is a disabling condition in which sufferers experience persistent and unexplained fatigue as well as any of a host of associated problems, including muscle weakness, pain, impaired memory, and disordered sleep. Medical treatment for CFS/ME costs as much as $7 billion every year in the U.S. alone.

The possible causes of CFS/ME have been argued and researched for years with no success. Results from separate studies in 2009 and 2010 that reported finding retroviruses in the blood of patients with CFS/ME created a sensation among patients and the medical community and offered hope that a tractable cause for this disease had finally been found. Since then, other investigators have been unable to replicate the results of those studies, casting doubt on the idea that these viruses, XMRV and pMLV, could be behind CFS/ME.

Sandamalgama, Sri Lanka - In this tiny Sri Lankan village, rice farmer Wimal Rajaratna sits cross-legged on a wooden bed, peering out toward lush palm trees that surround his home. Listless and weak, the 46-year old father of two anxiously awaits word on whether his body can accept a kidney donation that offers his only chance of survival.

In Uddanam, India, a reed-thin farmer named Laxmi Narayna prepares for the grueling two-day journey he takes twice every week. For most of his 46 years, his job involved shimmying up palm trees to harvest coconuts at the top. He now spends most of his time negotiating the more than 100-mile bus trips he takes to receive the dialysis treatments that keep him alive.

Ten thousand miles away, in the Nicaraguan community of La Isla, Maudiel Martinez dreads returning to the rolling sugarcane fields where he spent most of his teenage years at work with a machete. Blood tests by the sugar company that employed him found that his kidneys were seriously damaged - and exertion beneath the tropical sun could tip the 20-year-old's health into a lethal spiral.

In three countries on opposite ends of the world, these men face the same deadly mystery: their kidneys are failing, and no one knows why.

A mysterious form of chronic kidney disease - CKD - is afflicting thousands of people in rural, agricultural communities in Sri Lanka, India and Central America. The struggle to identify its causes is baffling researchers across multiple continents and posing a lethal puzzle worthy of Sherlock Holmes.

The three epidemics have crucial threads in common. The victims are relatively young and mostly farm workers, and few suffer from diabetes and high blood pressure, the usual risk factors for renal disease. They experience a rare form of kidney damage, known as tubulo-interstitial disease, consistent with severe dehydration and toxic poisoning.

Egged on by massive food-industry marketing budgets, Americans eat a lot of sugary foods. We know the habit is quite probably wrecking our bodies, triggering high rates of overweight and diabetes. Is it also wrecking our brains?

That's the disturbing conclusion emerging in a body of research linking Alzheimer's disease to insulin resistance - which is in turn linked to excess sweetener consumption. A blockbuster story in the Sept. 3 issue of the UK magazine The New Scientist teases out the connections.

It's a wonder people spend billions of dollars on woefully ineffective and even harmful pharmaceuticals when our own spice racks contain so much natural healing power. And now, many recent studies back the millennia-old claims that spices have powerful healing properties.

Here are 5 organic spices possessing amazing healing properties to bolster your well-being and protect you from illness and disease.